The DEA is publishing a rule change which impacts every patient who receives hydrocodone (Vicodin, Lortab, Norco, Vicoprofen). On approximately October 6th (final date will be 45 days from the official rule publication) all hydrocodone products will be moved up from schedule 3 to schedule 2 controlled substances, on par [...]